Download PDF
Semin Neurol 2007; 27(4): 376-384
DOI: 10.1055/s-2007-985338
Copyright © 2007 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Intracerebral Hemorrhage

Maria I. Aguilar1 , Bart M. Demaerschalk2
  • 1Department of Neurology, Division of Cerebrovascular Diseases, Mayo Clinic Arizona, Phoenix, Arizona
  • 2Department of Neurology, Divisions of Cerebrovascular Diseases and Critical Care Neurology, Mayo Clinic Arizona, Phoenix, Arizona
Further Information

Publication History

Publication Date:
15 August 2007 (online)

    Permissions and Reprints

ABSTRACT

Intracerebral hemorrhage has recently transitioned from being a neurosurgical entity into a condition where nonsurgeons have more participation in the medical decision making. Despite recent advances in the management of intracerebral hemorrhage (i.e., STICH trial and recombinant factor VII trial), guidelines published in 1999 remain the only available therapeutic consensus. The goal of this review is to address frequently encountered case scenarios when managing patients with spontaneous or nontraumatic intracerebral hemorrhage, both acutely and long-term.

KEYWORDS

Intracerebral hemorrhage - anticoagulants - antithrombotic therapy - thrombolysis - microbleeds

REFERENCES

  • 1 Brown D L, Boden-Albala B, Langa K M et al.. Projected costs of ischemic stroke in the United States [see comment].  Neurology. 2006;  67 1390-1395
    CrossrefPubMedGoogle Scholar
  • 2 Russell M W, Joshi A V, Neumann P J, Boulanger L, Menzin J. Predictors of hospital length of stay and cost in patients with intracerebral hemorrhage.  Neurology. 2006;  67 1279-1281
    CrossrefPubMedGoogle Scholar
  • 3 Taylor T N, Davis P H, Torner J C et al.. Lifetime cost of stroke in the United States.  Stroke. 1996;  27 1459-1466
    CrossrefPubMedGoogle Scholar
  • 4 Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group [see comment].  N Engl J Med. 1995;  333 1581-1587
    CrossrefPubMedGoogle Scholar
  • 5 Derex L, Hermier M, Adeleine P et al.. Clinical and imaging predictors of intracerebral haemorrhage in stroke patients treated with intravenous tissue plasminogen activator.  J Neurol Neurosurg Psychiatry. 2005;  76 70-75
    CrossrefPubMedGoogle Scholar
  • 6 Demchuk A M, Morgenstern L B, Krieger D W et al.. Serum glucose level and diabetes predict tissue plasminogen activator-related intracerebral hemorrhage in acute ischemic stroke.  Stroke. 1999;  30 34-39
    CrossrefPubMedGoogle Scholar
  • 7 Warach S, Latour L L. Evidence of reperfusion injury, exacerbated by thrombolytic therapy, in human focal brain ischemia using a novel imaging marker of early blood-brain barrier disruption.  Stroke. 2004;  35(suppl 1) 2659-2661
    CrossrefPubMedGoogle Scholar
  • 8 Mahaffey K W, Granger C B, Sloan M A et al.. Risk factors for in-hospital nonhemorrhagic stroke in patients with acute myocardial infarction treated with thrombolysis: results from GUSTO-I.  Circulation. 1998;  97 757-764
    CrossrefPubMedGoogle Scholar
  • 9 Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group [see comment] [erratum appears in Lancet 1994;343(8899):742].  Lancet. 1994;  343 311-322
    PubMedGoogle Scholar
  • 10 Gebel J M, Brott T G, Sila C A et al.. Decreased perihematomal edema in thrombolysis-related intracerebral hemorrhage compared with spontaneous intracerebral hemorrhage.  Stroke. 2000;  31 596-600
    PubMedGoogle Scholar
  • 11 Lee K R, Kawai N, Kim S, Sagher O, Hoff J T. Mechanisms of edema formation after intracerebral hemorrhage: effects of thrombin on cerebral blood flow, blood-brain barrier permeability, and cell survival in a rat model.  J Neurosurg. 1997;  86 272-278
    CrossrefPubMedGoogle Scholar
  • 12 Lee K R, Colon G P, Betz A L et al.. Edema from intracerebral hemorrhage: the role of thrombin.  J Neurosurg. 1996;  84 91-96
    CrossrefPubMedGoogle Scholar
  • 13 Dzialowski I, Pexman J H, Barber P A et al.. Asymptomatic hemorrhage after thrombolysis may not be benign: prognosis by hemorrhage type in the Canadian Alteplase for Stroke Effectiveness Study Registry.  Stroke. 2007;  38 75-79
    CrossrefPubMedGoogle Scholar
  • 14 Hallenbeck J M, Dutka A J. Background review and current concepts of reperfusion injury [erratum appears in Arch Neurol 1991;48(8):811].  Arch Neurol. 1990;  47 1245-1254
    PubMedGoogle Scholar
  • 15 Mahaffey K W, Granger C B, Sloan M A et al.. Neurosurgical evacuation of intracranial hemorrhage after thrombolytic therapy for acute myocardial infarction: experience from the GUSTO-I trial. Global Utilization of Streptokinase and tissue-plasminogen activator (tPA) for Occluded Coronary Arteries.  Am Heart J. 1999;  138 493-499
    CrossrefPubMedGoogle Scholar
  • 16 Manno E M, Atkinson J L, Fulgham J R, Wijdicks E F. Emerging medical and surgical management strategies in the evaluation and treatment of intracerebral hemorrhage.  Mayo Clin Proc. 2005;  80 420-433
    PubMedGoogle Scholar
  • 17 Mendelow A D, Gregson B A, Fernandes H M et al.. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial [see comment].  Lancet. 2005;  365 387-397
    CrossrefPubMedGoogle Scholar
  • 18 Rabinstein A A, Wijdicks E F. Surgery for intracerebral hematoma: the search for the elusive right candidate.  Rev Neurol Dis. 2006;  3 163-172
    PubMedGoogle Scholar
  • 19 Broderick J P, Adams Jr H P, Barsan W et al.. Guidelines for the management of spontaneous intracerebral hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association.  Stroke. 1999;  30 905-915
    CrossrefPubMedGoogle Scholar
  • 20 Mayer S A, Brun N C, Begtrup K et al.. Recombinant activated factor VII for acute intracerebral hemorrhage.  N Engl J Med. 2005;  352 777-785
    CrossrefPubMedGoogle Scholar
  • 21 Flaherty M L, Haverbusch M, Sekar P et al.. The increasing burden of anticoagulant-associated intracerebral hemorrhage[abstract].  Stroke. 2006;  37 623. Abstract 15
    PubMedGoogle Scholar
  • 22 Kucher N, Castellanos L R, Quiroz R et al.. Time trends in warfarin-associated hemorrhage.  Am J Cardiol. 2004;  94 403-406
    CrossrefPubMedGoogle Scholar
  • 23 Aguilar M I, Hart R G, Kase C S et al.. Treatment of warfarin-associated intracerebral hemorrhage: literature review and expert opinion.  Mayo Clin Proc. 2007;  82 82-92
    CrossrefPubMedGoogle Scholar
  • 24 Baker R I, Coughlin P B, Gallus A S et al.. Warfarin reversal: consensus guidelines, on behalf of the Australasian Society of Thrombosis and Haemostasis [see comment] [erratum appears in Med J Aust 2005;182(1):48].  Med J Aust. 2004;  181 492-497
    PubMedGoogle Scholar
  • 25 Ansell J, Hirsh J, Poller L et al.. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.  Chest. 2004;  126(suppl) 204S-233S
    CrossrefPubMedGoogle Scholar
  • 26 Schulman S. Clinical practice: care of patients receiving long-term anticoagulant therapy.  N Engl J Med. 2003;  349 675-683
    CrossrefPubMedGoogle Scholar
  • 27 Goldstein J N, Thomas S H, Frontiero V et al.. Timing of fresh frozen plasma administration and rapid correction of coagulopathy in warfarin-related intracerebral hemorrhage.  Stroke. 2006;  37 151-155
    CrossrefPubMedGoogle Scholar
  • 28 Butler A C, Tait R C. Restarting anticoagulation in prosthetic heart valve patients after intracranial haemorrhage: a 2-year follow-up.  Br J Haematol. 1998;  103 1064-1066
    CrossrefPubMedGoogle Scholar
  • 29 Lau C P, Chang C M, Lau G K et al.. Cerebral haemorrhage in anticoagulated patients with non-septic mechanical valvular prosthesis.  Int J Cardiol. 1991;  30 289-296
    CrossrefPubMedGoogle Scholar
  • 30 Nagano N, Tabata H, Hashimoto K. Anticoagulant-related intracerebral hemorrhage in patients with prosthetic heart valves: report of two cases.  Neurol Med Chir (Tokyo). 1991;  31 743-745
    PubMedGoogle Scholar
  • 31 Nakagawa T, Kubota T, Handa Y, Kawano H, Sato K. Intracranial hemorrhage due to long-term anticoagulant therapy in patients with prosthetic heart valves: four case reports.  Neurol Med Chir (Tokyo). 1995;  35 156-159
    PubMedGoogle Scholar
  • 32 Punthakee X, Doobay J, Anand S S. Oral-anticoagulant-related intracerebral hemorrhage.  Thromb Res. 2002;  108 31-36
    CrossrefPubMedGoogle Scholar
  • 33 Koennecke H C. Cerebral microbleeds on MRI: prevalence, associations, and potential clinical implications.  Neurology. 2006;  66 165-171
    CrossrefPubMedGoogle Scholar
  • 34 Eckman M H, Rosand J, Knudsen K A, Singer D E, Greenberg S M. Can patients be anticoagulated after intracerebral hemorrhage? A decision analysis.  Stroke. 2003;  34 1710-1716
    CrossrefPubMedGoogle Scholar
  • 35 Wani M, Nga E, Navaratnasingham R. Should a patient with primary intracerebral haemorrhage receive antiplatelet or anticoagulant therapy?.  BMJ. 2005;  331 439-442
    CrossrefPubMedGoogle Scholar
  • 36 Moulin T, Crepin-Leblond T, Chopard J L, Bogousslavsky J. Hemorrhagic infarcts.  Eur Neurol. 1994;  34 64-77
    CrossrefPubMedGoogle Scholar
  • 37 Lyden P D, Zivin J A. Hemorrhagic transformation after cerebral ischemia: mechanisms and incidence.  Cerebrovasc Brain Metab Rev. 1993;  5 1-16
    PubMedGoogle Scholar
  • 38 Amarenco P, Labreuche J, Lavallee P, Touboul P J. Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis.  Stroke. 2004;  35 2902-2909
    CrossrefPubMedGoogle Scholar
  • 39 Amarenco P, Bogousslavsky J, Callahan III A et al.. High-dose atorvastatin after stroke or transient ischemic attack [see comment].  N Engl J Med. 2006;  355 549-559
    CrossrefPubMedGoogle Scholar
  • 40 Collins R, Armitage J, Parish S et al.. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions [see comment].  Lancet. 2004;  363 757-767
    CrossrefPubMedGoogle Scholar
  • 41 Expert Panel on Detection EaToHBCiA . Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) [see comment].  JAMA. 2001;  285 2486-2497
    CrossrefPubMedGoogle Scholar
  • 42 Sacco R L, Adams R, Albers G et al.. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention.  Stroke. 2006;  37 577-617
    CrossrefPubMedGoogle Scholar
  • 43 Fazekas F, Kleinert R, Roob G et al.. Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds.  AJNR Am J Neuroradiol. 1999;  20 637-642
    PubMedGoogle Scholar
  • 44 Roob G, Schmidt R, Kapeller P et al.. MRI evidence of past cerebral microbleeds in a healthy elderly population.  Neurology. 1999;  52 991-994
    CrossrefPubMedGoogle Scholar
  • 45 Osborn A G. Diagnostic Neuroradiology. St. Louis, MO; Mosby 1994
    Google Scholar
  • 46 Fan Y H, Mok V C, Lam W W, Hui A C, Wong K S. Cerebral microbleeds and white matter changes in patients hospitalized with lacunar infarcts.  J Neurol. 2004;  251 537-541
    CrossrefPubMedGoogle Scholar
  • 47 Kato H, Izumiyama M, Izumiyama K, Takahashi A, Itoyama Y. Silent cerebral microbleeds on T2*-weighted MRI: correlation with stroke subtype, stroke recurrence, and leukoaraiosis.  Stroke. 2002;  33 1536-1540
    CrossrefPubMedGoogle Scholar
  • 48 Kwa V I, Franke C L, Verbeeten Jr B, Stam J. Silent intracerebral microhemorrhages in patients with ischemic stroke. Amsterdam Vascular Medicine Group [see comment].  Ann Neurol. 1998;  44 372-377
    CrossrefPubMedGoogle Scholar
  • 49 Greenberg S M, Eng J A, Ning M, Smith E E, Rosand J. Hemorrhage burden predicts recurrent intracerebral hemorrhage after lobar hemorrhage.  Stroke. 2004;  35 1415-1420
    CrossrefPubMedGoogle Scholar
  • 50 Naka H, Nomura E, Wakabayashi S et al.. Frequency of asymptomatic microbleeds on T2*-weighted MR images of patients with recurrent stroke: association with combination of stroke subtypes and leukoaraiosis.  AJNR Am J Neuroradiol. 2004;  25 714-719
    PubMedGoogle Scholar
  • 51 Wong K S, Chan Y L, Liu J Y, Gao S, Lam W W. Asymptomatic microbleeds as a risk factor for aspirin-associated intracerebral hemorrhages.  Neurology. 2003;  60 511-513
    PubMedGoogle Scholar
  • 52 Kidwell C S, Saver J L, Villablanca J P et al.. Magnetic resonance imaging detection of microbleeds before thrombolysis: an emerging application [see comment].  Stroke. 2002;  33 95-98
    CrossrefPubMedGoogle Scholar
  • 53 Derex L, Nighoghossian N, Hermier M et al.. Thrombolysis for ischemic stroke in patients with old microbleeds on pretreatment MRI.  Cerebrovasc Dis. 2004;  17 238-241
    CrossrefPubMedGoogle Scholar
  • 54 Ferro J M. Update on intracerebral haemorrhage.  J Neurol. 2006;  253 985-999
    PubMedGoogle Scholar
  • 55 Greenberg S M, Rebeck G W, Vonsattel J P, Gomez-Isla T, Hyman B T. Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy [see comment].  Ann Neurol. 1995;  38 254-259
    CrossrefPubMedGoogle Scholar
  • 56 Knudsen K A, Rosand J, Karluk D, Greenberg S M. Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria.  Neurology. 2001;  56 537-539
    CrossrefPubMedGoogle Scholar
  • 57 Gregory P C, Kuhlemeier K V. Prevalence of venous thromboembolism in acute hemorrhagic and thromboembolic stroke.  Am J Phys Med Rehabil. 2003;  82 364-369
    CrossrefPubMedGoogle Scholar
  • 58 Lacut K, Bressollette L, Le Gal G et al.. Prevention of venous thrombosis in patients with acute intracerebral hemorrhage.  Neurology. 2005;  65 865-869
    CrossrefPubMedGoogle Scholar
  • 59 Dickmann U, Voth E, Schicha H et al.. Heparin therapy, deep-vein thrombosis and pulmonary embolism after intracerebral hemorrhage.  Klin Wochenschr. 1988;  66 1182-1183
    CrossrefPubMedGoogle Scholar
  • 60 Counsell C, Boonyakarnkul S, Dennis M et al.. Primary intracerebral haemorrhage in the Oxfordshire Community Stroke Project.  Cerebrovasc Dis. 1995;  5 26-34
    PubMedGoogle Scholar
  • 61 The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group [see comment].  Lancet. 1997;  349 1569-1581
    CrossrefPubMedGoogle Scholar
  • 62 McCarthy S T, Turner J. Low-dose subcutaneous heparin in the prevention of deep-vein thrombosis and pulmonary emboli following acute stroke.  Age Ageing. 1986;  15 84-88
    CrossrefPubMedGoogle Scholar
  • 63 Lacut K, Bressollette L, Le Gal G et al.. Prevention of venous thrombosis in patients with acute intracerebral hemorrhage.  Neurology. 2005;  65 865-869
    CrossrefPubMedGoogle Scholar
  • 64 Geerts W H, Pineo G F, Heit J A. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.  Chest. 2004;  126(suppl) 338S-400S
    CrossrefPubMedGoogle Scholar

Maria I AguilarM.D. 

Department of Neurology, Division of Cerebrovascular Disease, Mayo Clinic Arizona

5777 East Mayo Boulevard, Phoenix, AZ 85054

      >